Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity
Authors:
- Janice C. LawJLJanice C. Law
- Franco M. RecchiaFRFranco M. Recchia
- David G. MorrisonDMDavid G. Morrison
- Sean P. DonahueSDSean P. Donahue
- Robert L. EstesRERobert L. Estes
- 1 February 2010
- journal article
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 14 (1) , 6-10
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot studyBritish Journal of Ophthalmology, 2008
- INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN) FOR TREATMENT OF STAGE 3 RETINOPATHY OF PREMATURITY IN ZONE I OR POSTERIOR ZONE IIRetina, 2008
- Vitreous Levels of Stromal Cell–Derived Factor 1 and Vascular Endothelial Growth Factor in Patients with Retinopathy of PrematurityOphthalmology, 2008
- OFF-LABEL USE OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR SALVAGE TREATMENT IN PROGRESSIVE THRESHOLD RETINOPATHY OF PREMATURITYRetina, 2008
- ANTIANGIOGENIC THERAPY WITH INTRAVITREAL BEVACIZUMAB FOR RETINOPATHY OF PREMATURITYRetina, 2008
- Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group StudyJournal of Clinical Oncology, 2008
- INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSIONRetina, 2007
- Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurityIndian Journal Of Ophthalmology, 2007
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Vascular Endothelial Growth Factor and Hepatocyte Growth Factor Levels Are Differentially Elevated in Patients with Advanced Retinopathy of PrematurityThe American Journal of Pathology, 2000